Medication of l-tetrahydropalmatine significantly ameliorates opiate craving and increases the abstinence rate in heroin users: A pilot study

Acta Pharmacologica Sinica

Volumn 29, Issue 7, 2008, Pages 781-788

  Yang, Zheng ^a   Shao, Yong Cong ^a,b   Li, Shi Jiang ^c   Qi, Jian Lin ^a,b   Zhang, Mei Jie ^d   Hao, Wei ^e   Jin, Guo Zhang ^f  

^a Beijing Institute of Basic Medical Sciences   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c Department of Biophysics ^*  (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e Central South University   (China)

^f SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Abstinence rate; Heroin addiction; Levo tetrahydropalmatine; Relapse

Indexed keywords

OPIATE; PLACEBO; TETRAHYDROPALMATINE; ANALGESIC AGENT; BERBERINE DERIVATIVE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DETOXIFICATION; DRUG EFFICACY; DRUG MECHANISM; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RELAPSE; SCORING SYSTEM; WITHDRAWAL SYNDROME; BIOASSAY; HEROIN DEPENDENCE; PATIENT; PILOT STUDY; PSYCHOLOGICAL ASPECT; RECURRENT DISEASE; TREATMENT OUTCOME;

ADULT; ANALGESICS, NON-NARCOTIC; BERBERINE ALKALOIDS; DOUBLE-BLIND METHOD; ENDPOINT DETERMINATION; FEMALE; HEROIN DEPENDENCE; HUMANS; MALE; PATIENT DROPOUTS; PILOT PROJECTS; RECURRENCE; TREATMENT OUTCOME;

EID: 65849233445     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2008.00817.x     Document Type: Article

References (42)

1. O'Brien CP. Anticraving medications for relapse prevention: a possible new class of psychoactive medications. Am J Psychiatr 2005; 162: 1423-31.
2. Haasen C, van den Brink W. Innovations in agonist maintenance t reatment of opioid-dependent pat ients. Cur r Opin Psychiatr 2006; 19: 631-6.
3. Sung S, Conry JM. Role of buprenorphine in the management of heroin addiction. Ann Pharmacother 2006; 40: 501-5.
4. Dackis C, O'Brien C. Neurobiology of addiction: treatment and public policy ramifications. Nat Neurosci 2005; 8: 1431-6.
5. Heidbreder CA, Hagan JJ. Novel pharmacotherapeutic approaches for the treatment of drug addiction and craving. Curr Opin Pharmacol 2005; 5: 107-18.
6. Kenny PJ, Chen SA, Kitamura O, Markou A, Koob GF. Conditioned withdrawal drives heroin consumption and decreases reward sensitivity. J Neurosci 2006; 26: 5894-900.
7. Xu SX, Yu LP, Han YR, Chen Y, Jin GZ. Effects of tetrahydroprotoberberines on dopamine receptor subtypes in brain. Acta Pharmacol Sin 1989; 10: 104-10.
8. Jin GZ. (-)-Tetrahydropalmatine and its analogues as new dopamine receptor antagonists. Trends Pharmacol Sci 1987; 8: 81-2.
9. Jin GZ, Wang XL, Shi WX. Tetrahydroprotoberberine - a new chemical type of antagonist of dopamine receptors. Sci Sin [B] 1986; 29: 527-34.
10. Jin GZ, Xu SX, Yu LP. Di fferent effects of enantiomers of tetrahydropalmatine on dopaminergic system. Sci Sin [B] 1986; 29; 1054-64.
11. He Y. The pharmacological properties of l-stepholidine on different dopamine receptor subtypes [PhD Dissertation]. Shanghai: Shanghai Institute of Materia Medica, 2005.
12. Hong Z, Fan G, Le J, Chai Y, Yin X, Wu Y. Brain pharmacokinetics and tissue distribution of tetrahydropalmatin enantiomers in rats after oral administration of the recemate. Biopharm Drug Dispos 2006; 27: 111-7.
13. Wang YB, RenYH, Zheng JW, Zeng I. Influence of l- tetrahydropalmatine on morphine-induced condi t ioned place preference. Chin Pharmacol Bull 2005; 21: 1442-5
14. Wang YB, Ren YH, Zheng JW. The effects of l-THP on morphine- induced discrimination. Chin J Drug Dependence 2005; 14: 27-9.
15. Liu YL, Liang JH, Yan LD, Su RB, Wu CF, Gong ZH. Effect of ltet rahydropalmatine on locomotor sensi tization to oxycodone in mice. Acta Pharmacol Sin 2005; 26: 533-8.
16. Heidbreder CA, Gardner EL, Xi ZX, Thanos PK, Mugnaini M, Hagan JJ, et al. The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence. Brain Res Rev 2005; 49; 77-105.
17. Pilla M, Perachon S, Sautel F, Garrido F, Mann A, Wermuth CG, et al. Selective inhibition of cocaine-seeking behaviour by a partial dopamine D-3 receptor agonist. Nature 1999; 400: 371- 5.
18. Kish SJ, Kalasinsky KS, Derkach P, Schmunk GA, Guttman M, Ang L, et al. Striatal dopaminergic and serotonergic markers in human heroin users. Neuropsychopharmacology 2001; 24: 561- 7.
19. Jin GZ. Discoveries in the voyage of corydalis research. Shanghai: Shanghai Scientific & Technical Publishers; 2001.
20. Chen HX, Hao W, Yang DS. The development of subject ive protracted withdrawal scales for opiate dependence. Chin J Mental Health 2003; 17; 294-7.
21. Scheike TH, Zhang MJ. Cumulative regression function tests for regression models for longitudinal data. Ann Statistics 1999; 26; 1328-55.
22. Scheike TH, Zhang MJ, Juul A. Comparing reference charts. Biometrical J 1999; 41; 679-787.
23. Luo JS, Ren YH, Zhu R. The effect of l-THP on cocaine-induced conditioned position preference. Chin J Drug Depend 2003; 12: 177-9.
24. Mantsch JR, Li SJ, Risinger R, Awad S, Katz E, Baker DA, et al. Levo-tetrahydropalmatine attenuates cocaine self-administration and cocaine-induced reinstatement in rats. Psychopharmacology 2007; 192: 581-91.
25. Xi ZX, Yang Z, Li SS, Li X, Dillon C, Pang XQ, et al. Levotetrahydropalmatine inhibits cocaine's rewarding effects: Experiments with self administration and brain-stimulation reward in rats. Neuropharmacology 2007; 53: 771-82.
26. Vorel SR, Ashby CR Jr, Paul M, Liu X, Hayes R, Hagan JJ, et al. Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats. J Neurosci 2002; 22: 9595-603.
27. Xi ZX, Gilbert J, Campos AC, Kline N, Ashby CR Jr, Hagan JJ, et al. Blockade of mesolimbic dopamine D3 receptors inhibits stressinduced reinstatement of cocaine-seeking in rats, Psychopharmacology (Berlin) 2004; 176; 57-65.
28. Xi ZX, Newman AH, Gilbert JG, Pak AC, Peng XQ, Ashby CR Jr, et al. The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats. Neuropsychopharmacology 2006; 31: 1393-405.
29. Pak AC, Ashby CR Jr, Heidbreder CA, Pilla M, Gilbert J, Xi ZX, et al . The select ive dopamine D3 receptor antagonist SB- 277011A reduces nicotine-enhanced brain reward and nicotinepaired environmental cue functions. Int J Neuropsychopharmacol 2006; 9: 585-602.
30. Joyce JN, Mi llan MJ. Dopamine D3 receptor antagonists as therapeutic agonists. Drug Dis Today 2005; 10: 917-25.
31. Hu JY, Jin GZ. Supraspinal D2 receptor involved in antinociception induced by l-tetrahydropalmatine. Acta Pharmacol Sin 1999; 20: 715-9.
32. Hu JY, Jin GZ. Arcuate nucleus of hypothalamus involved in analgesic action of l-THP. Acta Pharmacol Sin 2000; 21: 439- 44.
33. Ge XQ, Lin AP, Sun Y, Zhou HZ, Zhang HQ, et al. Effects of l-tetrahydropalmatine on opioid peptides contents in morphine dependent rats. Chin Pharmacol Bull 2001; 17: 264-6.
34. Liu YL, Liang JH, Yan LD, Su RB, Wu CF, Gong ZH. Effects of l-tetrahydropalmatine on locomotor sensitization to oxycodone in mice. Acta Pharmacol Sin 2005; 26: 533-8.
35. Wang W, Zhou Y, Sun J, Pan L, Kang L, Dai Z, et al. The effect of l-stephol idine, a novel ext r act of Chinese herb, on the acquisition, expression, maintenance, and re-acquisition of morphine conditioned place preference in rats. Neuropharmacology 2007; 52: 356-61.
36. Yang Z, Li CO, Fan M. Effect of tetrahydroprotoberberines on contents of glial fibrillary acidic protein and tyrosine hydroxylase in ventral tegmental area of morphine dependent rats. Chin J Pharmacol Toxicol 2003; 17: 246-50.
37. Yang Z, Li CQ, Fan M. Effects of tetrahydroprotoberberines on expression of dopamine system related genes in morphine dependent rats. Chin J Psychiatr 2004; 37: 111-5.
38. Marcenac F, Jin GZ, Gonon F. Effect of l-tetrahydropalmative on dopamine release and metabol ism in the ret st r iatums. Psychopharmcology 1986; 89: 89-93.
39. Huang KX, Sun BC, Gonon F, Jin GZ. Effects of tetrahydroprotoberberines on dopamine release and 3,4-dihydroxyphenylacetio acid level in corpus striatums measured by in vivo voltammetry. Acta Pharmacol Sin 1991; 12: 32-6.
40. Chen LJ, Guo X. Wang QM, Jin GZ. Feed-back regulation of presynapt ic D2 receptors block aded by l -st ephol idine and l- tetrahydropalmatine. Acta Pharmacol Sin 1992; 13: 442-5.
41. Hu JY, Jin GZ. Effect of tetrahydropalmatine analogs on Fos expression. Acta Pharmacol Sin 1999; 20:193-200.
42. Lai CK, Chan A YW. Tetrahydropalmatine poisoning: diagnoses of nine adult overdoses based on toxicology screens by HPLC wi th diode-ar r ay detect ion and Gas chromatography-mass spectrometry. Clin Chem 1999; 45: 229-36.